Azoramide - 10mM in DMSO, high purity , CAS No.932986-18-0

1 Citations
  • 10mM in DMSO
Item Number
A426981
Grouped product items
SKUSizeAvailabilityPrice Qty
A426981-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$103.90

Unfolded protein response (UPR) modulator

Basic Description

SynonymsAzoramide | 932986-18-0 | N-(2-(2-(4-CHLOROPHENYL)THIAZOL-4-YL)ETHYL)BUTYRAMIDE | N-[2-[2-(4-chlorophenyl)-4-thiazolyl]ethyl]-butanamide | N-[2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethyl]butanamide | N-{2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethyl}butanamide | SC1362
Specifications & Purity10mM in DMSO
Biochemical and Physiological MechanismsModulator of unfolded protein response (UPR). Protects cells from ER stress by improving ER protein folding and activating ER chaperone capacity. Also improves ER calcium retention. Improves liver ER function, glucose homeostasis and glucose-stimulated in
Storage TempStore at -80°C
Shipped InIce chest + Ice pads

Names and Identifiers

IUPAC Name N-[2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethyl]butanamide
INCHI InChI=1S/C15H17ClN2OS/c1-2-3-14(19)17-9-8-13-10-20-15(18-13)11-4-6-12(16)7-5-11/h4-7,10H,2-3,8-9H2,1H3,(H,17,19)
InChi Key VYBFWKKCWTXCQX-UHFFFAOYSA-N
Canonical SMILES CCCC(=O)NCCC1=CSC(=N1)C2=CC=C(C=C2)Cl
Isomeric SMILES CCCC(=O)NCCC1=CSC(=N1)C2=CC=C(C=C2)Cl
PubChem CID 7518316
Molecular Weight 308.83

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

Citations of This Product

1. Fengying Dai, Kepeng Lv, Bo Zhang, Junqiang Zhao, Shaoteng Wang, Ke Lan, Yiping Zhao, Xiaolei Zhang, Bohong Kan.  (2023)  Overcoming the structure deficiency of nanodrug coated with tannic acid shell through phenolic hydroxyl protection strategy for Alzheimer's disease combination treatment.  Biomaterials Advances,  154  (21): (213651).  [PMID:37827021]

References

1. Fengying Dai, Kepeng Lv, Bo Zhang, Junqiang Zhao, Shaoteng Wang, Ke Lan, Yiping Zhao, Xiaolei Zhang, Bohong Kan.  (2023)  Overcoming the structure deficiency of nanodrug coated with tannic acid shell through phenolic hydroxyl protection strategy for Alzheimer's disease combination treatment.  Biomaterials Advances,  154  (21): (213651).  [PMID:37827021]

Solution Calculators